Belief Biomed (beijing) Co., Ltd

This early-stage study is testing a new, one-time gene therapy called BBM-D101 for boys with Duchenne Muscular Dystrophy (DMD). The main goal is to see if the treatment is safe and well-tolerated. Researchers will also check if it helps improve muscle strength and function over a…

This is an early-stage study to test the safety and initial effectiveness of a new gene therapy called BBM-A101 for knee osteoarthritis. The therapy involves a single injection into the knee, designed to deliver a therapeutic gene to help control the disease. The study will enrol…